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Problem Definition

Intervention

Glucose metabolism is a complex process consisting of
several physiologic mechanisms that function to regulate
serum glucose levels and maintain them within a fairly
narrow range in healthy individuals. Hypoglycemia is
characterized by a reduction in plasma glucose
concentration to a level low enough, typically less than
60 mg/dL, to cause symptoms or systemic effects,
classically adrenergic stimulation or altered mental
status. Hypoglycemia is most frequently seen in patients
with diabetes following insulin injection or intake of oral
hypoglycemic agents. In the patient without diabetes,
hypoglycemia is much less common and often warrants
further investigation to determine the cause.

In reviewing data from hypoglycemia evaluations
performed within our institution it is appears that the
workup is often incomplete or yields uninterpretable
results.

Hospitalized patients are high risk for hypoglycemia
because acute and chronic illness can cause altered
counterregulatory responses and the development of
life-threatening sequelae. Controlling blood glucose in
hospitalized patients is important as both hyperglycemia
and hypoglycemia are associated with increased cost,
length of stay, morbidity and mortality. Avoidance and
recognition of hypoglycemia is essential to patient safety
and studies have confirmed higher mortality rates with
spontaneous rather than iatrogenic hypoglycemia.
Therefore, hypoglycemia of unclear cause may be viewed
as a biomarker systemic disease and mandates
appropriate investigation to determine the etiology.

While this data is limited and represents a very small
subset of patients, it is supportive of the need for a
standardized institutional ‘hypoglycemic diagnostic
protocol’ that will allow for staff to obtain all relevant
laboratory data needed to complete the diagnostic
workup without delaying treatment. We are confident
that implementation of this simple, user-friendly and
cost-effective protocol will lead to improved patient
outcomes and institutional quality measures.
Measurement and Results
In review of charts of 11 patients recently admitted to
Thomas Jefferson University Hospital (TJUH) for whom
a complete biochemical evaluation of hypoglycemia was
obtained:
• 2/11 (18%) of evaluations yielded clinically significant
data, 82% of initial testing was inconclusive (Fig 1.)
• 1/11 (9%) of patients for whom the workup
was performed had true hypoglycemia (<60ngdL)
•

4/11 patients (36%) lacked confirmatory blood
glucose levels (Fig 2)
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Next Steps and Lessons Learned
To improve patient safety and diagnostic value of testing, we
propose a provider-driven protocol for testing needed in evaluation
of true hypoglycemia. The narrow investigative window in such
instances, while blood glucose is still low prior to temporizing
measures, often limits the opportunity to obtain the appropriate
diagnostic testing. It is critically important to confirm that the
plasma glucose is indeed low (<60 mg/dL). Serology for additional
testing should be obtained simultaneously for use/analysis if
hypoglycemia is confirmed. Whipple’s triad of low plasma glucose,
symptoms of hypoglycemia at the time of the low glucose, and
symptom relief with treatment of hypoglycemia should also be
confirmed on all patients.
Such additional laboratory testing is directed at evaluation for
potential hormone and metabolic imbalances, toxic ingestions,
and/or enzymatic defects. This can be done via immediate blood
draw of at least two gold-top tubes and labs ordered via protocol
(as below).
Advanced testing, as included in our proposed order set, should
include the following:

Aims For Improvement
It is the aim of our quality improvement project to create
a standardized method to appropriately assess and
treat hypoglycemia in the inpatient setting such that the
needed components of the diagnostic evaluation can be
obtained in an expedited, cost-effective and patient
safety-oriented manner. We plan to design of an
inpatient hypoglycemia order set which can be used as
an easily accessible reference and clinical tool.

• Basic Metabolic Panel (plasma glucose, electrolytes)
• Plasma insulin levels, Pro-insulin levels, Cpeptide levels
• Serum lactate and ketones (beta-hydroxybutyrate
where available), Urine ketones.
• Thyroid, adrenal (random cortisol), liver function tests
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• In almost half of all cases, testing had to be repeated.
(Fig 3.)

• We recommend obtaining both TSH and Free T4
• Cortisol level at the time of hypoglycemia is appropriate
if >14 mcg/dL
• Spot sulfonylurea screen (send out)
• Toxicology screen (UDS, ethanol, salicylates), as appropriate.

